Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
about
Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsInteraction between circulating cancer cells and platelets: clinical implicationPlatelets, coagulation and fibrinolysis in breast cancer progressionNanoparticle-induced platelet aggregation and vascular thrombosisDifferential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.Living in shear: platelets protect cancer cells from shear induced damage.Platelets and cancer: a casual or causal relationship: revisited.Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in miceFormulation and storage of platelet-rich plasma homemade product.Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs.Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisThe platelet contribution to cancer progression.Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.Platelets, circulating tumor cells, and the circulome.Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases.Cancer and Thrombotic Risk: The Platelet Paradigm.Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?Role of ADP receptors on platelets in the growth of ovarian cancer.Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q.Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.Role of platelets and platelet receptors in cancer metastasis
P2860
Q24623647-764A17D4-87A8-42CD-BB33-6CE6F89987DDQ26778920-DA25D1EB-B9A2-4957-B276-B8BB656E1E56Q26823716-BF07EEA3-0EF6-4E37-8CD0-13DBBF542557Q28191813-E2E7F5B2-AC23-4E7C-B626-1653BDBF0639Q30453962-4822960D-9FA9-4D7F-B311-B0FCFDC90DF6Q30468939-B5BCEC4C-F760-44BB-A775-33DDCC1B792CQ33415986-85897C1C-40F7-4FC0-A8F7-BECCDBF88C12Q34294719-C37009B2-2874-427F-A614-BDAE9A00E03EQ35048404-198604F1-7304-43CD-9EC1-5812DCEBACE9Q35153802-7D8C94CA-30DA-4E1A-89A8-A7743AE19BD3Q35832620-078CF094-FD8C-440A-8F64-10EF2412C023Q36574499-439AAB9B-382D-436C-ADA3-F2791321594FQ36611493-63975C21-D092-455F-800A-578316C133CDQ36618989-A3B2EE34-83E7-46C4-86A8-A82ED6D173C4Q37805788-E1C1C8CE-E9C7-4BE2-BE1B-7683855A3110Q38174455-2413D774-8D70-4A4E-A505-53255A6F3554Q39408199-AE59F2A6-A0A0-48E0-BD56-EF20E6152A1CQ40597413-1E431881-39CC-47C7-B2F4-98D2EC722429Q40897159-329FDFFF-AE98-4818-A2F5-DAFA2E78F535Q41141633-E01C1CCC-8AE8-4B25-8612-1464117A96E4Q41420993-CA73C91E-D56B-49B6-BDBF-07BBB6EF5587Q41430279-EBF89A20-F363-49A3-983F-D9FD02AD7CE1Q41877140-6D55202F-AA24-4500-B1B5-D84F3ED42D3CQ43261615-D256C3A8-DDDB-43D8-BA65-DFAED951FC2CQ44264785-FC7350C4-FC3D-4C4E-8108-6CB7C8D185E4Q44522050-25EAD356-C52A-4F6B-BB98-8A839A10CF17Q45869485-2450AA3F-441D-4A61-89F7-5AD41607C386Q46617653-1A3E4F15-70A8-4D28-999A-5C8D29562BFEQ47400340-2433E2A3-89FA-498C-895C-E4AE354AA580Q51730485-FF67D9CC-6095-4915-ACAF-8F8762A24729Q55398181-3BE5A63C-1057-4987-98D1-68FA7EB67B33Q57280930-7A2809D2-5FE6-4C96-9479-2626D814E231
P2860
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Membrane type-1 matrix metallo ...... ole of receptor glycoproteins.
@en
type
label
Membrane type-1 matrix metallo ...... ole of receptor glycoproteins.
@en
prefLabel
Membrane type-1 matrix metallo ...... ole of receptor glycoproteins.
@en
P2093
P2860
P356
P1476
Membrane type-1 matrix metallo ...... ole of receptor glycoproteins.
@en
P2093
Ada W Chung
David Alonso-Escolano
Elena I Deryugina
Marek W Radomski
P2860
P304
P356
10.1038/SJ.BJP.0705606
P407
P577
2003-12-22T00:00:00Z